The world of clinical research has seen a pronounced shift in how clinical trials are conducted. Hear from Anthony Costello, CEO of Patient Cloud at Medidata, as he discusses with Harvard Business Review on what DCTs mean for patients, doctors, and pharmaceutical companies.